Match tier
Listed
Presence
Formerly Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-06
A
Ashim K. Bagchi
Role not yet determined Is this you? Add your title
Formerly Arkansas Affiliated with UAMS through 2024; recent publications list University of Manitoba.
18 h-index
67 pubs
1,290 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ashim K. Bagchi's research focuses on understanding the molecular mechanisms underlying cardiovascular diseases, particularly in the context of diabetes and oxidative stress. His work investigates how cellular processes like apoptosis and signal transduction are altered in conditions such as heart failure and doxorubicin-induced cardiomyopathy. Bagchi has explored the protective effects of various compounds, including Vitamin C and oleic acid, against oxidative and nitrosative stress in cardiac cells. He also studies the role of signaling pathways, such as NF-κB and Akt, in regulating inflammatory responses and cell survival in the cardiovascular system. His research has been supported by collaborations with colleagues at the University of Arkansas for Medical Sciences, including Amanda J. Stolarz, Rushita A. Bagchi, Soumiya Pal, and Jawahar L. Mehta. Bagchi has published 67 papers, accumulating 1,290 citations, with an h-index of 18.
Metrics
- h-index: 18
- Publications: 67
- Citations: 1,290
Selected Publications
-
Obesity, histone acetylation, and insulin resistance (2024)
-
List of contributors (2024)
-
Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats (2024)
-
Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts (2024)
-
JoVE Video Dataset (2024)
-
Real-Time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels (2024)
-
Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways (2024)
-
The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress (2023)
-
Lipidomic Predictors of Coronary No-Reflow (2023)
-
Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats (2022)
-
NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases (2022)
-
The Structural Basis of Effective LOX-1 Inhibition (2022)
-
Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy (2022)
Collaboration Network
Top Collaborators
Pawan K. Singal
St. Boniface Hospital (CA)
5 shared publications
- Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
- Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
- Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways
- Lipidomic Predictors of Coronary No-Reflow
- The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress
Akshi Malik
St. Boniface Hospital (CA)
4 shared publications
- Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
- Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
- Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways
- The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress
Davinder S. Jassal
St. Boniface Hospital (CA)
4 shared publications
- Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
- Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
- Doxorubicin‑induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways
- The cardioprotective effects of Empagliflozin in Doxorubicin-induced endoplasmic reticulum (ER) stress
Amanda J. Stolarz
University of Arkansas for Medical Sciences
4 shared publications
In database
- Real-Time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
- JoVE Video Dataset
- Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts
- Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats
Soumiya Pal
University of Arkansas for Medical Sciences
3 shared publications
In database
- Real-Time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
- JoVE Video Dataset
- Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats
Anya Dhar
University of Michigan (US)
3 shared publications
- Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts
- List of contributors
- Obesity, histone acetylation, and insulin resistance
Rushita A. Bagchi
University of Arkansas for Medical Sciences
3 shared publications
In database
- Proteomics Approach to Identify Anthracycline-induced Cardiotoxicity Mechanisms in Human Cardiac Fibroblasts
- List of contributors
- Obesity, histone acetylation, and insulin resistance
Jawahar L. Mehta
Central Arkansas Veterans Healthcare System
2 shared publications
In database
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
- The Structural Basis of Effective LOX-1 Inhibition
Rajshekhar A. Kore
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- The Structural Basis of Effective LOX-1 Inhibition
Kottayil I. Varughese
University of Arkansas for Medical Sciences (US)
1 shared publication
- The Structural Basis of Effective LOX-1 Inhibition
W. T. K. Cheng
First Affiliated Hospital of Xinxiang Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Can Cui
First Affiliated Hospital of Xinxiang Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Gang Liu
Henan Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Chenji Ye
Henan Medical University (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Shao Fang
Zhengzhou Central Hospital (CN)
1 shared publication
- NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases
Similar Researchers
Based on overlapping research topics
Ji Li
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Tong Mu
University of Arkansas – Fort Smith
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Mehta Jl
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Andrew Morris
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Prathyusha Bagam
National Center for Toxicological Research
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Xu Wang
Arkansas Agricultural Experiment Station
Cardiovascular Function and Risk Factors
Disease Mechanisms Research
Receptor Mechanisms and Signaling